In vivo assessment of HER2 receptors expression, using NIR fluorescence imaging with affibody-dylight probe

Victor Chernomordik; Moinuddin Hassan; Yasaman Ardeshirpour; Rafal Zielinski; Jacek Capala; Amir Gandjbakhche

doi:10.1364/biomed.2012.bm2a.3

In vivo assessment of HER2 receptors expression, using NIR fluorescence imaging with affibody-dylight probe

Victor Chernomordik, Moinuddin Hassan, Yasaman Ardeshirpour, Rafal Zielinski, Jacek Capala, Amir Gandjbakhche

Experimental Therapeutics

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Abstract

Her2 overexpression in different carcinoma types is assessed in vivo (mouse model), using time sequences of fluorescence images after injection of HER2-specific fluorescent probes with fast pharmacokinetics. Comparison with flow cytometry results substantiates our approach.

Original language	English (US)
Title of host publication	Biomedical Optics, BIOMED 2012
Publisher	Optical Society of America (OSA)
Pages	BM2A.3
ISBN (Print)	9781557529428
DOIs	https://doi.org/10.1364/biomed.2012.bm2a.3
State	Published - 2012
Event	Biomedical Optics, BIOMED 2012 - Miami, FL, United States Duration: Apr 28 2012 → May 2 2012

Publication series

Name	Biomedical Optics, BIOMED 2012

Other

Other	Biomedical Optics, BIOMED 2012
Country/Territory	United States
City	Miami, FL
Period	4/28/12 → 5/2/12

ASJC Scopus subject areas

Biotechnology
Atomic and Molecular Physics, and Optics

Access to Document

10.1364/biomed.2012.bm2a.3

Cite this

In vivo assessment of HER2 receptors expression, using NIR fluorescence imaging with affibody-dylight probe. / Chernomordik, Victor; Hassan, Moinuddin; Ardeshirpour, Yasaman et al.
Biomedical Optics, BIOMED 2012. Optical Society of America (OSA), 2012. p. BM2A.3 (Biomedical Optics, BIOMED 2012).

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Chernomordik, V, Hassan, M, Ardeshirpour, Y, Zielinski, R, Capala, J & Gandjbakhche, A 2012, In vivo assessment of HER2 receptors expression, using NIR fluorescence imaging with affibody-dylight probe. in Biomedical Optics, BIOMED 2012. Biomedical Optics, BIOMED 2012, Optical Society of America (OSA), pp. BM2A.3, Biomedical Optics, BIOMED 2012, Miami, FL, United States, 4/28/12. https://doi.org/10.1364/biomed.2012.bm2a.3

@inproceedings{fcbf78538a154298933ed85ea8cb9574,

title = "In vivo assessment of HER2 receptors expression, using NIR fluorescence imaging with affibody-dylight probe",

abstract = "Her2 overexpression in different carcinoma types is assessed in vivo (mouse model), using time sequences of fluorescence images after injection of HER2-specific fluorescent probes with fast pharmacokinetics. Comparison with flow cytometry results substantiates our approach.",

author = "Victor Chernomordik and Moinuddin Hassan and Yasaman Ardeshirpour and Rafal Zielinski and Jacek Capala and Amir Gandjbakhche",

year = "2012",

doi = "10.1364/biomed.2012.bm2a.3",

language = "English (US)",

isbn = "9781557529428",

series = "Biomedical Optics, BIOMED 2012",

publisher = "Optical Society of America (OSA)",

pages = "BM2A.3",

booktitle = "Biomedical Optics, BIOMED 2012",

}

TY - GEN

T1 - In vivo assessment of HER2 receptors expression, using NIR fluorescence imaging with affibody-dylight probe

AU - Chernomordik, Victor

AU - Hassan, Moinuddin

AU - Ardeshirpour, Yasaman

AU - Zielinski, Rafal

AU - Capala, Jacek

AU - Gandjbakhche, Amir

PY - 2012

Y1 - 2012

N2 - Her2 overexpression in different carcinoma types is assessed in vivo (mouse model), using time sequences of fluorescence images after injection of HER2-specific fluorescent probes with fast pharmacokinetics. Comparison with flow cytometry results substantiates our approach.

AB - Her2 overexpression in different carcinoma types is assessed in vivo (mouse model), using time sequences of fluorescence images after injection of HER2-specific fluorescent probes with fast pharmacokinetics. Comparison with flow cytometry results substantiates our approach.

UR - http://www.scopus.com/inward/record.url?scp=84890766711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890766711&partnerID=8YFLogxK

U2 - 10.1364/biomed.2012.bm2a.3

DO - 10.1364/biomed.2012.bm2a.3

M3 - Conference contribution

AN - SCOPUS:84890766711

SN - 9781557529428

T3 - Biomedical Optics, BIOMED 2012

SP - BM2A.3

BT - Biomedical Optics, BIOMED 2012

PB - Optical Society of America (OSA)

T2 - Biomedical Optics, BIOMED 2012

Y2 - 28 April 2012 through 2 May 2012

ER -

In vivo assessment of HER2 receptors expression, using NIR fluorescence imaging with affibody-dylight probe

Abstract

Publication series

Other

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this